AI Verdict
BSX has stronger fundamentals based on our AI analysis.
BSX vs CVS Fundamental Comparison
| Metric | BSX | CVS |
|---|---|---|
| Revenue | $5.2B | $100.4B |
| Net Income | $1.3B | $2.9B |
| Net Margin | 25.8% | 2.9% |
| ROE | 5.2% | 3.8% |
| ROA | 3.0% | 1.2% |
| Current Ratio | 1.90x | 0.87x |
| Debt/Equity | 0.42x | 0.78x |
| EPS | $0.90 | $2.30 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BSX vs CVS: Frequently Asked Questions
Is BSX or CVS the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), BSX has stronger fundamentals. BSX is graded A (77% confidence) while CVS is graded C (75% confidence). This is not investment advice.
How does BSX compare to CVS fundamentally?
BOSTON SCIENTIFIC CORP has ROE of 5.2% vs CVS HEALTH Corp's 3.8%. Net margins are 25.8% vs 2.9% respectively.
Which stock pays higher dividends, BSX or CVS?
BSX has a dividend yield of N/A or no dividend while CVS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BSX or CVS for long term?
For long-term investing, consider that BSX has a A grade with 77% confidence, while CVS has a C grade with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BSX vs CVS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BSX vs CVS, the AI consensus favors BSX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.